Philip L. Johnson, EVP & Chief Financial Officer at Jazz Pharmaceuticals plc (JAZZ), bought 27,932 shares at $119.65 ($1.4M) on 2024-03-01, disclosed to the SEC on 2024-03-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,932 | $0 | 0.0% |
| 2 | $119.65 | 12,000 | $1.4M | 100.0% |
| Total | $51.40 avg | 27,932 | $1.4M | 100% |